Budur Kumar 4

What Happened

• Budur Kumar, Chief Medical Officer of Harmony Biosciences (HRMY), had restricted stock units (RSUs) vest on May 1, 2026. 18,750 RSUs were converted into common shares. To satisfy tax withholding, 8,882 shares were withheld by the issuer at $31.83 per share (total = $282,714), resulting in 9,868 net shares issued to Kumar.
• This was not an open-market purchase or sale by the insider; it reflects RSU vesting and issuer withholding to cover taxes.

Key Details

• Transaction date: May 1, 2026. Form filed: May 18, 2026 (filed 17 days after the transactions).
• Reported entries: conversion/exercise of derivatives (code M) for 18,750 shares and tax withholding (code F) of 8,882 shares at $31.83/share (≈ $282,714).
• Net shares received: 18,750 − 8,882 = 9,868 shares.
• Footnotes:
  • F1 — This filing corrects a prior Form 4 (filed Jan 26, 2026) that inadvertently misstated post-transaction ownership.
  • F2 — Shares withheld by the issuer to satisfy required income tax withholding upon RSU vesting.
  • F3 — The RSU award was granted May 1, 2024 and vests in four equal annual installments beginning May 1, 2025, subject to continued service.
• Shares beneficially owned after the transaction were not specified in the data provided here (see the full Form 4 for exact post-transaction ownership).

Context

• The conversion of RSUs into shares and the withholding of shares for taxes is a common, routine event tied to compensation vesting; it does not represent an open-market sale by the officer.
• Purchases by insiders are often viewed as stronger signals of bullishness; vesting and withholding events are typically neutral and driven by compensation agreements.
• Note the filing was submitted well after the usual two-business-day Form 4 deadline; the filing also states it corrects an earlier misstatement.